CLINICAL TRIALS PROFILE FOR AMBIEN
✉ Email this page to a colleague
All Clinical Trials for AMBIEN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00042146 ↗ | Behavioral and Pharmacological Treatment for Insomnia | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2001-12-01 | This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (AmbienĀ®), for chronic insomnia. |
NCT00042146 ↗ | Behavioral and Pharmacological Treatment for Insomnia | Completed | Laval University | Phase 4 | 2001-12-01 | This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (AmbienĀ®), for chronic insomnia. |
NCT00044629 ↗ | Combined Behavioral/Pharmacological Therapy for Insomnia | Completed | National Institute of Mental Health (NIMH) | Phase 2 | 2001-09-01 | This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia. |
NCT00044629 ↗ | Combined Behavioral/Pharmacological Therapy for Insomnia | Completed | Duke University | Phase 2 | 2001-09-01 | This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia. |
NCT00086281 ↗ | Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients | Completed | Jazz Pharmaceuticals | Phase 4 | 2003-11-01 | To study the effect of Xyrem (9 g), Xyrem (9 g) plus modafinil 200 mg administered the morning prior to Xyrem, positive control (zolpidem 10 mg), and placebo on the frequency and outcome of events of sleep-disordered breathing in patients with obstructive sleep apnea syndrome (OSAS). |
NCT00156533 ↗ | Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing | Completed | Sanofi-Synthelabo | Phase 4 | 2005-03-01 | We want to assess whether "how and when" one takes sleep medication results in similar or different outcomes with respect to symptom relief. We also want to know whether taking medication for a period of time provides continued benefit once the medication is stopped. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AMBIEN
Condition Name
Clinical Trial Locations for AMBIEN
Trials by Country
Clinical Trial Progress for AMBIEN
Clinical Trial Phase
Clinical Trial Sponsors for AMBIEN
Sponsor Name